Search
Search Results
-
The role of cytoreductive surgery in multifocal/multicentric glioblastomas
PurposeMultifocal/multicentric glioblastomas (mGBM) account for up to 20% of all newly diagnosed glioblastomas. The present study investigates the...
-
Advanced endometrial cancers—outcome of patients undergoing cytoreductive surgery: a retrospective study
ObjectivesThe objective of the study was to assess the overall and disease free survival in patients with advanced (Stage III and IV) endometrial...
-
The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis
BackgroundResidual disease following cytoreductive surgery in patients with ovarian cancer has been associated with poorer survival outcomes compared...
-
Impact of Successful Implementation of an Enhanced Recovery After Surgery Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
BackgroundCytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) are complex operations for the treatment of peritoneal...
-
Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery
BackgroundThe delivery of multimodal treatment at a high-volume center is known to optimize the outcomes of gastrointestinal malignancies. However,...
-
Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
BackgroundColorectal peritoneal metastases (CRPM) are present in 10–20% of patients at the time of their initial cancer diagnosis, and affects over...
-
Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006)
BackgroundThis report describes the oncologic outcomes for patients with advanced ovarian cancer who had bowel surgery performed by gynecologic...
-
Imaging of pre- and post-cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pediatric intraperitoneal malignancy
Although rare, pediatric peritoneal carcinomatosis does occur in primary abdominopelvic tumors. Additionally, peritoneal carcinomatosis has been...
-
Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery
BackgroundSeveral studies have demonstrated that secondary cytoreductive surgery (SCS) for patients with recurrent uterine malignancies may improve...
-
The Prognostic Impact of Splenectomy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
In this study, we aimed to investigate the prognostic impact of splenectomy on post-operative complications and the long-term oncologic results of...
-
Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
BackgroundThere have been no studies concerning the complications or benefits of cholecystectomy in ovarian cancer. In this study, we aimed to...
-
Bilateral Thoracic Cytoreductive Surgery for Pseudomyxoma Peritonei of Appendiceal Origin
Pleural spread occurs in pseudomyxoma peritonei (PMP) in less than 10% of the patients and is treated by thoracic cytoreductive surgery with or...
-
Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer
IntroductionTo evaluate the efficacy of cytoreductive surgery versus chemotherapy for the treatment of limited regional, platinum-resistant ovarian...
-
Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report
Gallbladder cancer is a rare cancer, associated with an extremely poor prognosis. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy...
-
Adoption of an Enhanced Recovery After Surgery Protocol Increases Cost of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Does not Improve Outcomes
BackgroundEnhanced recovery after surgery (ERAS) protocols have been shown to reduce length of stay (LOS) and complications. The impact of ERAS...
-
Incisional hernias post cytoreductive surgery/peritonectomy and hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis
PurposeCytoreductive surgery (CRS) is often combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of peritoneal tumour...
-
Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)
BackgroundCytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for patients with peritoneal carcinomatosis is promising...
-
Morbidity and mortality of patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
BackgroundThe purpose of this study was to record the incidence, and identify the prognostic variables of morbidity and mortality in patients with...
-
Reliability of bioreactance and pulse power analysis in measuring cardiac index during cytoreductive abdominal surgery with hyperthermic intraperitoneal chemotherapy (HIPEC)
PurposeVarious malignancies with peritoneal carcinomatosis are treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy...
-
Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
BackgroundCytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) causes considerable hemodynamic, respiratory, and...
